Your browser is no longer supported. Please, upgrade your browser.
Settings
MNK Mallinckrodt Public Limited Company daily Stock Chart
MNK [NYSE]
Mallinckrodt Public Limited Company
Index- P/E2.40 EPS (ttm)12.84 Insider Own0.40% Shs Outstand83.31M Perf Week-2.47%
Market Cap2.57B Forward P/E4.14 EPS next Y7.45 Insider Trans0.00% Shs Float81.53M Perf Month12.15%
Income1.18B PEG0.27 EPS next Q1.93 Inst Own- Short Float25.84% Perf Quarter-14.32%
Sales2.64B P/S0.97 EPS this Y902.60% Inst Trans-7.86% Short Ratio9.63 Perf Half Y91.31%
Book/sh79.37 P/B0.39 EPS next Y4.80% ROA11.30% Target Price31.00 Perf Year37.71%
Cash/sh3.49 P/C8.83 EPS next 5Y8.88% ROE26.40% 52W Range11.65 - 36.65 Perf YTD36.61%
Dividend- P/FCF3.29 EPS past 5Y148.40% ROI12.60% 52W High-15.91% Beta1.63
Dividend %- Quick Ratio2.10 Sales past 5Y13.50% Gross Margin50.40% 52W Low164.55% ATR1.42
Employees3900 Current Ratio2.20 Sales Q/Q6.60% Oper. Margin6.20% RSI (14)60.50 Volatility4.43% 5.63%
OptionableYes Debt/Eq0.94 EPS Q/Q121.40% Profit Margin65.20% Rel Volume0.88 Prev Close30.82
ShortableYes LT Debt/Eq0.93 EarningsNov 06 BMO Payout0.00% Avg Volume2.19M Price30.82
Recom2.90 SMA208.22% SMA507.83% SMA20040.45% Volume0 Change0.00%
Nov-19-18Upgrade Canaccord Genuity Hold → Buy $34 → $40
Sep-11-18Downgrade Goldman Neutral → Sell
Aug-24-18Reiterated B. Riley FBR Neutral $20 → $37
Aug-08-18Reiterated Stifel Hold $18 → $30
Aug-08-18Downgrade Raymond James Outperform → Mkt Perform
May-09-18Reiterated Barclays Underweight $20 → $12
May-02-18Initiated B. Riley FBR, Inc. Neutral $15
Mar-09-18Reiterated Mizuho Neutral $21 → $16
Feb-02-18Downgrade Barclays Equal Weight → Underweight $23 → $20
Jan-09-18Reiterated Mizuho Neutral $22 → $21
Jan-03-18Initiated Leerink Partners Mkt Perform $26
Nov-08-17Reiterated Canaccord Genuity Buy $38 → $24
Nov-08-17Downgrade Wells Fargo Outperform → Market Perform
Nov-08-17Downgrade Goldman Buy → Neutral
Nov-08-17Downgrade Barclays Overweight → Equal Weight $65 → $23
Nov-07-17Downgrade Deutsche Bank Buy → Hold $44 → $28
Sep-28-17Initiated Goldman Buy $55
Sep-06-17Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-16-17Initiated Cantor Fitzgerald Overweight $52
May-09-17Reiterated Canaccord Genuity Buy $91 → $87
Nov-19-18 12:33PM  Mallinckrodt Stock Can Rally Another 27%, Says Analyst Barrons.com
11:15AM  Canaccord Turns Bullish On Mallinckrodt: 4 Reasons Why Benzinga
Nov-16-18 08:08AM  The Daily Biotech Pulse: Mallinckrodt FDA Verdict, European Cheer For Bristol-Myers Squibb, Morphosys Clinches Licensing Deal Benzinga
Nov-15-18 04:09PM  Mallinckrodt Gets FDA Committee Vote for Abuse-Deterrent Drug Zacks
08:45AM  Consolidated Research: 2018 Summary Expectations for Tapestry, Mallinckrodt public limited company, Moxian, Applied Genetic Technologies, VistaGen Therapeutics, and Oasis Midstream Partners LP Fundamental Analysis, Key Performance Indications GlobeNewswire
08:10AM  The Daily Biotech Pulse: FDA Nod For Mallinckrodt's Pain Drug, AbbVie-Neurocrine Report Positive Elagolix Results Benzinga
Nov-14-18 05:08PM  Mallinckrodt's SpecGx LLC Reports on Outcome of FDA Joint Advisory Committee on Abuse-Deterrent, Immediate-Release Reformulation of Roxicodone® (Oxycodone Hydrochloride) PR Newswire
08:17AM  The Daily Biotech Pulse: Mallinckrodt Faces FDA Panel, Reshape's Earnings, Vapotherm To Debut Benzinga
Nov-13-18 12:51PM  Which Pharmaceutical Stocks Are Outperforming All Other Stocks? Investor's Business Daily
Nov-12-18 05:00PM  Mallinckrodt To Present At BMO Prescriptions For Success Healthcare Conference PR Newswire
Nov-09-18 08:09AM  Mallinckrodt Presents Terlipressin Clinical Data at The Liver Meeting® 2018 PR Newswire
Nov-08-18 06:45AM  Mallinckrodt Earns International Standard ISO 13485:2016 and Medical Device Single Audit Program (MDSAP) Certifications for INOmax® DSIR® Plus Nitric Oxide Delivery Systems PR Newswire
Nov-07-18 04:08PM  Mallinckrodt (MNK) Beats on Q3 Earnings Estimates, Ups View Zacks
09:44AM  Company News For Nov 7, 2018 Zacks
06:55AM  Today's Research Reports on Trending Tickers: Mallinckrodt Public Limited and OPKO Health ACCESSWIRE
06:30AM  The Market Is Finally Embracing Long-Unloved Drug Stocks Barrons.com
Nov-06-18 05:21PM  Edited Transcript of MNK earnings conference call or presentation 6-Nov-18 1:30pm GMT Thomson Reuters StreetEvents +9.13%
04:47PM  Mallinckrodt Pops On Quarter Beat As Lilly Dips On Mixed Report Investor's Business Daily
12:38PM  Wall Street Advances on Tuesday GuruFocus.com
09:30AM  MNK or AMPH: Which Is the Better Value Stock Right Now? Zacks
09:10AM  Should Value Investors Buy Mallinckrodt (MNK) Stock? Zacks
07:55AM  Mallinckrodt (MNK) Surpasses Q3 Earnings and Revenue Estimates Zacks
07:43AM  Stocks making the biggest move premarket: CVS, Eli Lilly, Marriott, Mylan & more CNBC
06:52AM  Mallinckrodt: 3Q Earnings Snapshot Associated Press
06:00AM  Mallinckrodt plc Reports Third Quarter 2018 Results and Raises Earnings Guidance for 2018 PR Newswire
Nov-05-18 01:17PM  Q3 Earnings Preview For Mallinckrodt Benzinga
Nov-02-18 06:45AM  Leading Hepatorenal Expert Joins Mallinckrodt's Scientific Advisory Council PR Newswire
Nov-01-18 09:26AM  Attention Biotech Investors: Mark Your Calendar For These November PDUFA Dates Benzinga +6.94%
Oct-26-18 06:45AM  First Patient Screened in Mallinckrodt Phase 4 Trial of H.P. Acthar® Gel (Repository Corticotropin Injection) for Severe Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis PR Newswire
Oct-24-18 12:27PM  Republic Services sues Mallinckrodt in wake of EPA plan for landfill American City Business Journals -6.51%
Oct-23-18 04:30PM  Mallinckrodt and the Lupus Foundation of America Present Data from Survey of Over 1,500 Individuals with Self-Reported Lupus at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting PR Newswire
Oct-22-18 06:45AM  Mallinckrodt Presents Data on H.P. Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting PR Newswire
Oct-19-18 09:29AM  Mallinckrodt (MNK) Gets $26 Million as Funding From BARDA Zacks
Oct-16-18 06:45AM  Mallinckrodt To Present At Jefferies London Healthcare Conference PR Newswire
Oct-15-18 06:45AM  Mallinckrodt's Stratatech Company Awarded $26 Million in Additional BARDA Funding for Pediatric Studies of StrataGraft® Skin Tissue in Thermal Burns PR Newswire
Oct-12-18 01:37PM  How St. Louis stocks weathered this weeks tumble American City Business Journals
Oct-09-18 01:04PM  Opioid antidote inventor: We're in the 'next phase of this opioid crisis' Yahoo Finance
Oct-08-18 06:28PM  Generic-Drugs Stock Outlook: No Respite from Pricing Issues Zacks
06:45AM  U.S. FDA Announces Joint Advisory Committee Review of Mallinckrodt's Abuse-Deterrent, Immediate-Release Reformulation of Roxicodone® (Oxycodone Hydrochloride) PR Newswire
Oct-05-18 03:38PM  Q&A: Synthetic blood startup's new CEO hopes to bring product to hospitals, battlefields and eventually Mars American City Business Journals
12:15PM  Jefferies: Reaction In Mallinckrodt Shares To Praxair Competition Overblown Benzinga
08:00AM  Today's Research Reports on Trending Tickers: Eli Lilly and Company and Mallinckrodt ACCESSWIRE
Oct-04-18 05:26PM  Today's market winners & losers Yahoo Finance Video -17.29%
04:32PM  Why Mallinckrodt, International Speedway, and LGI Homes Slumped Today Motley Fool
Oct-02-18 09:30AM  MNK or AMPH: Which Is the Better Value Stock Right Now? Zacks
Sep-28-18 09:59AM  Forget Mylan, Invest in These 3 Generic/Drug Stocks Instead Zacks
Sep-26-18 10:09AM  Opioid legislation could lift certain hospital operators, drugmakers MarketWatch
Sep-25-18 09:00AM  Dance Biopharm Holdings announces the appointment of Anne Whitaker as Chief Executive Officer GlobeNewswire
06:45AM  Mallinckrodt plc To Report Earnings Results For Third Quarter Of Fiscal 2018 PR Newswire
Sep-20-18 09:35AM  Is Mallinckrodt (MNK) a Great Stock for Value Investors? Zacks
Sep-14-18 02:29PM  Is Mallinckrodt Public Limited Companys (NYSE:MNK) PE Ratio A Signal To Buy For Investors? Simply Wall St.
Sep-11-18 06:15PM  Goldman's Specialty Pharma Pair Trade: Sidelined On Endo, Bearish On Mallinckrodt Benzinga
Sep-06-18 10:04AM  Why Is Mallinckrodt (MNK) Up 14.9% Since Last Earnings Report? Zacks
Sep-04-18 06:45AM  Mallinckrodt To Present At Cantor Global Healthcare Conference PR Newswire
Aug-31-18 06:06PM  Edited Transcript of MNK earnings conference call or presentation 7-Aug-18 12:30pm GMT Thomson Reuters StreetEvents
Aug-27-18 09:10AM  Are Investors Undervaluing Mallinckrodt (MNK) Right Now? Zacks
Aug-23-18 09:10AM  Mallinckrodt's Stannsoporfin Gets Complete Response Letter Zacks
07:50AM  New Research Coverage Highlights Live Nation Entertainment, LightPath Technologies, Synchronoss Technologies, Mallinckrodt public limited company, Capricor Therapeutics, and Mersana Therapeutics Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Aug-22-18 08:20AM  The Daily Biotech Pulse: FDA Snub For Allergan, Myriad's Q4 Beat, Mallinckrodt's Stannsoporfin Benzinga
07:02AM  Mallinckrodt confirms FDA has rejected a treatment for babies at risk of developing jaundice MarketWatch
06:45AM  Mallinckrodt Confirms Receipt of Stannsoporfin Complete Response Letter PR Newswire
Aug-21-18 08:00AM  Today's Research Reports on Trending Tickers: Mallinckrodt and Perrigo Company ACCESSWIRE
Aug-20-18 03:08PM  The Week Ahead: Alibaba, More Retail Earnings Take Center Stage Benzinga
Aug-19-18 12:00PM  The Week Ahead In Biotech: Conferences, PDUFA Dates And Earnings Benzinga
Aug-17-18 08:00AM  Today's Research Reports on Trending Tickers: Mallinckrodt Public and Zogenix ACCESSWIRE
Aug-16-18 01:53PM  Trump administration proposes production quota cuts for six opioids Reuters +5.27%
Aug-14-18 09:36AM  13 of the Cheapest Healthcare Stocks Motley Fool
Aug-13-18 08:50AM  Moving Average Crossover Alert: Mallinckrodt Public (MNK) Zacks
Aug-10-18 09:30AM  MNK vs. AMPH: Which Stock Should Value Investors Buy Now? Zacks
06:45AM  Mallinckrodt To Present At Wells Fargo Securities 2018 Healthcare Conference PR Newswire
Aug-09-18 06:45AM  New Mallinckrodt Data Analysis Shows Limited Use Of Opioid-Free Analgesia, Underutilization In Some Patients More Prone To Opioid-Related Adverse Events PR Newswire
Aug-08-18 10:49AM  Mallinckrodt (MNK) Beats on Q2 Earnings and Sales, Ups View Zacks
10:45AM  Company News For Aug 8, 2018 Zacks
10:03AM  Mallinckrodt Downgraded By Raymond James On Lack Of 'Rational Valuation Framework' Benzinga
08:33AM  Mallinckrodt downgraded to market perform by Raymond James MarketWatch
07:57AM  Mallinckrodt stock rises 21% on sales of its most controversial product MarketWatch
Aug-07-18 11:44AM  Why Mallinckrodt PLC Stock Is Surging 23% Today Motley Fool +20.90%
08:48AM  Options Traders Expect Huge Moves in Mallinckrodt (MNK) Stock Zacks
07:46AM  Stocks making the biggest moves premarket: CI, BHC, MNK, DF, MAR, Z & more CNBC
06:46AM  Mallinckrodt's stock shoots higher after profit and revenue beat, raised outlook MarketWatch
06:34AM  Mallinckrodt: 2Q Earnings Snapshot Associated Press
06:30AM  Mallinckrodt Plc to Host Earnings Call ACCESSWIRE
06:00AM  Mallinckrodt plc Reports Second Quarter 2018 Results and Raises Guidance for 2018 PR Newswire
Aug-06-18 08:00AM  Today's Research Reports on Trending Tickers: Mylan and Mallinckrodt ACCESSWIRE
08:00AM  Mallinckrodt Forms Collaborative Research Partnership with Washington University in St. Louis PR Newswire
Aug-02-18 06:00PM  U.S. subpoenas AmerisourceBergen over opioid products Reuters
06:45AM  First Patient Enrolled in Mallinckrodt's Phase 2 Duchenne Muscular Dystrophy Trial PR Newswire
Aug-01-18 04:45PM  Mallinckrodt Initiates Proof-of-Concept Study of Nitric Oxide Gas in Ex-Vivo System of Human Lung Transplants PR Newswire
Jul-19-18 11:50AM  Drug Firms Blame Opioid Crisis on Illicit Websites, Dealers Bloomberg
Jul-11-18 07:45AM  Free Stock Performance Review on Mallinckrodt and Three Additional Generic Drugs Stocks ACCESSWIRE
Jul-09-18 06:30AM  New Health Economic Data on Mallinckrodt's OFIRMEV® (Acetaminophen) Injection Published in Journal of Knee Surgery PR Newswire
Jul-04-18 09:30AM  Should Value Investors Consider Mallinckrodt (MNK) Stock? Zacks
Jun-28-18 04:45PM  Mallinckrodt Rheumatoid Arthritis Phase 4 Clinical Study for H.P. Acthar® Gel (Repository Corticotropin Injection) Achieves its Enrollment Target PR Newswire
Jun-26-18 11:18AM  Is Mallinckrodt Public Limited Company (NYSE:MNK) A Financially Sound Company? Simply Wall St.
Jun-22-18 06:30AM  Mallinckrodt plc To Report Earnings Results For Second Quarter Of Fiscal 2018 PR Newswire
Jun-21-18 04:45PM  Mallinckrodt Launches Scientific Advisory Council PR Newswire
Jun-18-18 08:10AM  Report: Exploring Fundamental Drivers Behind Tile Shop Holdings, Anworth Mortgage Asset, Advanced Disposal Services, PacWest, Workday, and Mallinckrodt New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
06:30AM  Mallinckrodt Reports Interim Findings Of H.P. Acthar® Gel (Repository Corticotropin Injection) Studies PR Newswire
Jun-11-18 01:00PM  GoPro Is Among Seven Stocks Poised for a Reversal TheStreet.com
Jun-01-18 07:40AM  Free Stock Performance Review on Mallinckrodt and Three Additional Generic Drugs Stocks ACCESSWIRE
Mallinckrodt public limited company develops, manufactures, markets, and distributes branded pharmaceutical products in Canada and the European Union, as well as in Latin American, the Middle Eastern, African, and the Asia-Pacific regions. The company markets branded pharmaceutical products for autoimmune and rare diseases in the specialty areas of neurology, rheumatology, nephrology, ophthalmology, and pulmonology; and immunotherapy and neonatal respiratory critical care therapies, as well as analgesics and gastrointestinal products. It offers H.P. Acthar Gel, an injectable drug for various indications, such as proteinuria, multiple sclerosis, infantile spasms, ophthalmic, neuromuscular disorders, dermatomyositis, polymyositis, rheumatology, and pulmonology; Inomax, a vasodilator to enhance oxygenation and reduce the need for extracorporeal membrane oxygenation; Ofirmev, an intravenous formulation of acetaminophen for pain management; Therakos, an immunotherapy treatment platform; and Amitiza for the treatment of chronic idiopathic constipation. The company is also developing StrataGraft, which is in Phase III and II clinical development for the treatment of burns; terlipressin for the treatment of hepatorenal syndrome; MNK-1411 for the treatment of Duchenne muscular dystrophy; Stannsoporfin, a heme oxygenase inhibitor for the treatment of jaundice; Xenon gas for inhalation; MNK-6105, an ammonia scavenger for the treatment of hepatic encephalopathy, a neuropsychiatric syndrome associated with hyperammonemia; VTS-270 that is in Phase III development for Niemann-Pick Type C, a neurodegenerative fatal disease; and CPP-1X/sulindac, which is in Phase III development for Familial Adenomatous Polyposis. Mallinckrodt public limited company markets its branded products to physicians, pharmacists, pharmacy buyers, hospital procurement departments, ambulatory surgical centers, and specialty pharmacies. The company is based in Staines-Upon-Thames, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Trudeau MarkPresident and CEOMay 16Buy15.543,00046,615269,961May 18 04:46 PM
Flynn James E10% OwnerMay 09Sale13.39312,9284,189,8188,308,455May 10 04:51 PM
YOUNGBLOOD DR KNEELANDDirectorNov 28Buy21.944,560100,04619,789Nov 30 09:08 AM